Effect of the extract from salivary glands of Lucilia sericata on human neutrophils

Neuroendocrinology Letters

Volumn 29, Issue 5, 2008, Pages 794-797

  Pečivová, Jana ^a   Mačičková, Tatiana ^a   Takáč, Peter ^b   Kovácsová, Mária ^b   Cupaníková, Daniela ^c   Kozánek, Milan ^b  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b Inst Zool Slovak Acad of Sci   (Slovakia)

^c National Transfusion Service   (Slovakia)

Author keywords

Maggot therapy; Myeloperoxidase; Phagocytes; Reactive oxygen species; Superoxide

Indexed keywords

MYELOPEROXIDASE; NATURAL PRODUCT; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL ISOLATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LUCILIA SERICATA; MAGGOT; MALE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PROTEIN DETERMINATION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION;

EID: 57149142083     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bexfield A, Nigam Y, Thomas S, Ratcliffe NA (2004). Detection and partial characterization of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). Microbes Infect. 6:1297-1304.
2. Cambal M, Labas R Kozanek M, Takac P, Krumpalova Z (2006). Maggot debridement therapy. Bratisl.Lek.Listy 107: 442-4.
3. Chan DCW, Fong DHF, Leung JYY, Patil NG, Leung GKK (2007). Maggot debridement therapy in chronic wound care. Hong Kong Med.J. 13: 382-6.
4. Dovi JV, Szpaderska AM, Di Pietro LA (2004). Neutrophil function in the healing wound: adding insult to injury? Thromb Haemost. 92: 275-280.
5. Drábiková K, Jančinová V, Nosál' R, Solík P, Murín J, Holomáňová D (2006). On the antioxidant activity of carvedilol in human polymorphonuclear leukocytes in vitro and ex vivo Neuroendocrinol Lett. 27: 138-140
6. Gupta AMS (2008). A review of the use of maggots in wound therapy. Annals of Plastic Surgery. 60 (2): 224-227.
7. Jančinová V, Drábiková K, Nosál' R, Račková L, Májeková M, Holomáňová D (2006). The combined luminol/ isoluminol chemiuminescence method for differentiating between extracellular andintracellular oxidant production by neutrophils. Redox Report. 11: 110-116.
8. Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, Gehling UM, et al. (2005). Myeloperoxidase mediates neutrophil activation by association with CD11b/CD 18 integrins. Proc Natl Acad Sci USA 102: 431-436.
9. Lojek A, Kubala L, Čížová H, Číž M (2002). A comparison of whole blood neutrophil chemiluminescence measured with cuvette and microtitre luminometers. Luminescence. 17: 1-4.
10. Maes M, Mihaylova I, Bosmans E (2007). Not in the mind of neurastenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta. Neuroendocrinol Lett. 28: 456-62.
11. Nigam Y, Bexfield A, Thomas S, Ratcliffe NA (2006). Maggot Therapy: The Science and Implication for CAM Part II - Maggots Combat Infection. eCAM. 3(3): 303-308.
12. Pečivová J, Mačičková T, Lojek A, Gallová L., Číž M., Nosál' R, et al. (2006). Effect of carvedilol on reactive oxygen species and enzymes linking innate and adaptive immunity. Neuroendocrinol Lett. 27: 160-163
13. Pečivová, J., Mačičková T., Lojek A., Gallová L., Číž M., Nosál' R, et al. (2007). In vitro effect of carvedilol on professional phagocytes. Pharmacology. 79: 86-92.
14. Sherman RA, Hall MJR, Thomas S (2000). Medicinal maggots: An ancient remedy for some contemporary afflictions. Annu.Rev.Entomol. 45: 55-81
15. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem&Cell Biol. 39: 44-84.
16. Van der Plas MJA, Van der Does AM, Baldry M, Dogterom-Ballering HCM, Van Gulpen C, Van Dissel JT, et al. (2007). Maggot excretions/ secretions inhibit multiple neutrophil pro-inflammatory responses. Microbes and infection. 9: 507-514.
17. Vojtassak J, Danisovic L, Kubes M, Bakos D, Jarabek L, Ulicna M, et al. (2006). Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuroendocrinol Lett. 27: 134-137.